A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...
(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ivan de Kouchkovsky discussing the impact of baseline PSMA PET in patients with metastatic ...
The latest figures on prostate cancer are shocking: it has officially overtaken breast cancer as the most commonly diagnosed ...
The incorporation of all these biomarkers into routine screening could revolutionise prostate cancer management by enabling ...
PROSTATE cancer (PCa) screening through serum PSA testing has been shown to significantly reduce mortality rates. The ...
Truly game-changing’ prostate cancer test backed by Sir Chris Hoy could help tens of thousands of men - Dr Matthew Hobbs, ...
Les Ferdinand is backing a partnership between Prostate Cancer UK and the MOBO Awards 2025 - which will take place in ...
An emergency physician has pinpointed a trio of "worrying" symptoms that might signal a lethal cancer accountable for nearly ...
Approximately 10–20% of prostate cancer patients develop mCRPC within 5−7 years of diagnosis. 3 Between 1.2–2.1% of all prostate cancer cases globally are mCRPC. 4 The Phase 3 TALAPRO-2 trial is a ...
Oxford BioDynamics announced on Wednesday that it has signed a distribution agreement with Regina Maria, Romania’s largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback